Evotec and Centogene sign partnership on drug discovery projects in rare genetic diseases

28-Aug-2018 - Evotec AG announced that CENTOGENE AG and Evotec entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic diseases. Evotec and CENTOGENE initiated the collaboration to develop a strategic high-throughput platform for ...

QIAGEN and CENTOGENE to collaborate in bioinformatics for genetic diseases

Aiding the analysis of hereditary disorders by integrating genomic and clinical databases

11-Oct-2017 - QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and CENTOGENE AG announced a collaboration and co-marketing agreement to provide customers more complete Sample to Insight research and clinical testing solutions in rare genetic diseases. CENTOGENE is a leading rare disease company providing ...

CENTOGENE raises Euro 25 million

14-Jun-2017 - CENTOGENE AG, announced today its 25 million EUR Series A financing round led by TVM Capital Life Science in collaboration with DPE Deutsche Private Equity, Careventures and CIC Capital. The proceeds of the financing will be used to accelerate the company’s further growth and expansion plans in ...

Centogene is strengthening senior management team

12-Jul-2011 - Centogene Holding AG announced that Christine Uekert, formerly executive in IT businesses at SPM Technologies and SAP and Life Science at ProBioGen and OD-OS, and Dr Stefan Maeser, formerly executive of Life Technologies, Arcensus and Genzyme, have joined the group of diagnostic laboratories, as ...

Prof. Jürgen Kohlhase New Director Human Genetics of Centogene

24-Mar-2011 - Centogene Holding AG announced that Prof. Jürgen Kohlhase, MD, Founder of the Center of Human Genetics Freiburg, Germany, became cooperation partner of Centogene Holding AG and was appointed Director Human Genetics. Internationally the group operates under the name of Centogene as an active ...

Michael Schlenk New Chief Executive Officer of Centogene Holding AG

20-Jan-2011 - Centogene Holding AG (formerly Arcensus AG) announced that Michael Schlenk, former CEO of ProBioGen AG joined the management as Chief Executive Officer effective January 2011. He also invested and became a major shareholder. In addition to many years as management consultant in the area of ...